(Reuters) -U.S. intelligence officials in late February told senators working on a biotech security bill that Chinese pharmaceutical firm WuXi AppTec had transferred U.S. intellectual property to Beijing without consent, according to two sources. The U.S. government is concerned that certain Chinese biotech companies are contributing technology or research and development for use by China's military, and the proposed legislation would restrict U.S. government funds going to those Chinese companies. The classified briefing to about a dozen senators was led by the FBI, the State Department and the Office of the Director of National Intelligence.
The US government is concerned that certain Chinese biotech companies are contributing technology or research and development for use by China s military, and the proposed legislation would restrict US government funds going to those Chinese companies.
A WuXi AppTec spokesperson said: "We are not aware of any unauthorized transfers by WuXi AppTec of any U.S. client s data or intellectual property to China. Safeguarding our customers information is of the utmost importance to us, and we store it in keeping with their direction."
A bill introduced by a bipartisan group of Select Committee Members in the Senate and the House could severely impact U.S. companies' ability and desire to contract with biotechnology.
Alliance for Building Better Medicine receives $1M award virginiabusiness.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from virginiabusiness.com Daily Mail and Mail on Sunday newspapers.